Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
i-PRF for Orthodontic En Masse Retraction
NCT05608356Unknown
- Sponsor
- Cairo University
- Start
- Dec 2022
- Primary completion
- Nov 2023
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Randomised, double-blind trial of platelet rich fibrin in malocclusion (2 arms), sponsored by Cairo University. Primary endpoint: Rate of En masse retraction at 4 months. Status: unknown.
02
Drugs
platelet rich fibrin
03
Conditions
malocclusion
Beyond the preview
Go deeper on NCT05608356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05608356.